October 25, 2011
Mochida Pharmaceutical announced on October 24 that it upwardly revised its consolidated and non-consolidated business forecasts for the first half of FY2012 (April to September 2011). Its pharmaceutical business grew steadily, such as higher-than-expected sales for some mainstay products, and...read more